Vital Tears Names Joseph Tauber, MD as Chief Medical Officer

Vital Tears, known for its innovative autologous serum tears, is excited to announce the appointment of Joseph Tauber, MD, to the role of Chief Medical Officer (CMO). This strategic addition aims to fortify the company’s commitment to leading-edge research, physician education, and improved patient access to serum tear therapy.

As CMO, Dr. Tauber is tasked with steering Vital Tears’ research and development endeavors, focusing on advancing the science behind autologous serum tears. His role encompasses educating physicians and providing extensive training to ensure they are well-equipped to offer this treatment. Furthermore, Dr. Tauber will serve as the pivotal medical bridge between Vital Tears and the wider medical community, fostering essential dialogue and cooperation.

A significant part of his responsibilities includes advocating for broader insurance coverage of serum tears, a critical step towards making this treatment more accessible to patients in need.

Dr. Tauber, an esteemed ophthalmologist based in Kansas City, Missouri, brings a wealth of knowledge and expertise to Vital Tears. His educational journey led him from Harvard Medical School to completing dual fellowship training in both the treatment and surgery of corneal diseases and ocular immunology. Recognized internationally for his work on ocular surface disease and as a leading expert in dry eye treatment, Dr. Tauber also specializes in managing complex ocular infections regionally.

His extensive research portfolio includes serving as a principal investigator in more than 150 studies, covering areas such as high-risk corneal transplantation, eye inflammation and allergies, infectious corneal diseases, and various aspects of dry eye syndrome.